drugset / Trial / NCT01848899

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

NCT01848899

Phase 4 Completed 100 enrolled NYU Langone Health Guerbet · collab
RandomizedParallel-groupSingle-blind

Summary

The aim of this study is to determine how two different types of iodinated contrast media (CM) agents, low-osmolar ionic ioxaglate and iso-osmolar non-ionic iodixanol, affect specific markers of thrombogenesis and platelet function in patients undergoing coronary angiography, and if the use of bivalirudin, a direct thrombin inhibitor used during percutaneous coronary intervention (PCI), affects any contrast-related changes in thrombogenesis and platelet function.

Timeline

Start
2013-02
Primary completion
2013-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Iodixanol Diagnostic / imaging agent
Subject Ioxaglate Diagnostic / imaging agent
Background Bivalirudin Peptide